Define your product and franchise strategy from pre-launch to end-of-lifecycle.
Rely on our expertise to guide your product and franchise strategy at every point of the commercialization journey from pre-launch to end-of-lifecycle. Our strategic guidance and tailored customer engagement models are fit for pharmaceutical commercial strategy success in an evolving world.
Whether you’re looking to commercialize a new product or advance an established one, our experts will help you understand the market opportunity and develop winning strategies to pursue it.
The foundation of a successful launch is a deep understanding of the science, competitive landscape, real-world clinical practice, stakeholder needs, and engagement opportunities that surround it.
Changing the trajectory of marketed brands and franchises requires an unbiased perspective willing to challenge convention with a deep understanding of market dynamics and ability to support leadership alignment and field execution.
We can help with:
Our experts can support the development of your go-to-market strategy centered on a future-proofed customer engagement model to help you unlock value and drive performance.
Get the latest insights and perspectives from our experts.
Learn how Putnam reviewed the paths took by five prominent biotech companies to establish itself as a successful commercial-stage organization.
An emerging biotech sought Putnam’s guidance to design and execute the global commercialization of its asset for a rare oncology indication.
A rapidly shifting healthcare landscape and a wave of cost-containment initiatives destined to put further pressure on the pricing of pharmaceuticals.
Over the last decade, rare diseases have represented an increasingly popular growth avenue to offset the challenges faced in other mature franchises.
Looking to get in touch with an expert or team member?
Tell us how we can help.
